WINFertility Announces the Addition of Board-Certified Reproductive Endocrinologist Dr. Daniel E. Stein as Medical Director
Dr. Daniel E. Stein to Provide Clinical Oversight, Further Augmenting WINFertility's Clinical Advocacy In Support of Growth
GREENWICH, Conn., Aug. 10, 2021 /PRNewswire-PRWeb/ -- WINFertility (WIN), the nation's leading fertility benefits management company with the largest portfolio of employer clients, announces the addition of board-certified reproductive endocrinologist Daniel E. Stein, MD as Medical Director. As Medical Director, Dr. Stein will be a clinical resource for WIN's Nurse Care Managers and patients and their partners. He will augment WIN's medical director capabilities to support WIN's growth in clients and case volume. Dr. Stein will also continue to serve on WINFertility's Medical Advisory Board, composed of leading academic and community-based reproductive endocrinologists.
"We are honored to have Dr. Stein expand his role and join us as a Medical Director", said Roger Shedlin, M.D., J.D., President and CEO of WIN. "Dr. Stein's clinical expertise helps provide our members with clinical advocacy and oversight to support our goal of enabling patients to achieve the highest quality clinical outcomes."
"I am proud to join WINFertility as it has been leading access to fertility sponsored care for employers, health plans, and patients for more than two decades" says Dr. Daniel Stein. I look forward to contributing to WINFertility's outstanding clinical care team and its leadership in managed fertility care."
Daniel E. Stein, MD is a board-certified reproductive endocrinologist and the Director of RMA of New York's Westside office. He is Chief of the Division of Reproductive Endocrinology at Mount Sinai West Hospital and on the faculty of the Department of Obstetrics and Gynecology at the Icahn School of Medicine at Mount Sinai. Dr. Stein has 25 years of experience in Reproductive Endocrinology and Infertility. He earned his medical degree at New York Medical College and completed his residency in Obstetrics and Gynecology at Thomas Jefferson University Hospital in Philadelphia, and a fellowship in Reproductive Endocrinology at UMDNJ-New Jersey Medical School. Dr. Stein has numerous publications in peer-reviewed journals. His primary interests are in the management of infertility and recurrent implantation failure as well as recurrent pregnancy loss. He is consistently named a Top Doctor by US News & World Report, and for the past many years has been recognized as one of New York's "Best Doctors" by New York Magazine and Castle Connolly.
About WINFertility
WINFertility is the nation's leading family-building and fertility benefit management company, providing comprehensive solutions for employers, health plans and consumers. From fertility management, including medical treatment, pharmacy and genetics to surrogacy and adoption, WIN has helped more than 100,000 families by providing access to the best doctors, technology, and support. WINFertility works with the nation's leading reproductive endocrinologists and integrates with national and regional insurance carriers, as well as the nation's largest pharmacy benefit managers, to deliver the most advanced and effective fertility treatments and family-building solutions. WIN Nurse Care Managers navigate patients through the often-complex process, providing clinical oversight, emotional support, advocacy, and education throughout the journey. Patients and clients that utilize WIN's program see higher pregnancy rates, fewer multiple gestations, more efficient Rx utilization, and lower costs. WINFertility is a privately held company located in Greenwich, CT.
Media Contact
Stacy Callahan, Astonish Media Group, +1 (917) 972-1101, [email protected]
SOURCE WINFertility
Share this article